Lombard Odier Asset Management (USA)’s Evolent Health EVH Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-180,000	Closed	-$1.29M	–	255
2019 Q3	$1.29M	Sell	180,000 -705,000	-80%	-$5.06M	0.12%	167
2019 Q2	$7.04M	Buy	885,000 +812,900	+1,127%	+$9.62M	0.57%	60
2019 Q1	$907K	Sell	72,100 -37,900	-34%	-$600K	0.07%	177
2018 Q4	$2.19M	Sell	110,000 -96,000	-47%	-$2.22M	0.17%	127
2018 Q3	$5.85M	Buy	206,000 +181,000	+724%	+$4.32M	0.43%	80
2018 Q2	$526K	Sell	25,000 -276,900	-92%	-$5.24M	0.03%	229
2018 Q1	$4.3M	Sell	301,900 -77,541	-20%	-$1.11M	0.31%	90
2017 Q4	$4.67M	Buy	379,441 +79,441	+26%	+$1.12M	0.36%	84
2017 Q3	$5.34M	Buy	+300,000	New	+$6.18M	0.38%	82
2017 Q1	–	Sell	-80,000	Closed	-$1.18M	–	222
2016 Q4	$1.18M	Buy	+80,000	New	+$1.58M	0.15%	126

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s EVH Position: Q4 2019 in Review

Lombard Odier Asset Management (USA) sold out of Evolent Health (EVH) in Q4 2019, closing a stake of 180,000 shares — an estimated $1.29M sold.

Lombard Odier Asset Management (USA) first reported a position in EVH in Q4 2016 and held it in 10 quarters. The position peaked at $7.04M in Q2 2019. 167 funds tracked by Wall St. Rank hold EVH as of Q4 2019.

Lombard Odier Asset Management (USA) reported no remaining Evolent Health position as of Q4 2019 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 180,000 Evolent Health shares in Q4 2019, an estimated $1.29M.
Lombard Odier Asset Management (USA) first reported a position in Evolent Health in Q4 2016 and held it in 10 quarters.
Lombard Odier Asset Management (USA)'s Evolent Health position peaked at $7.04M in Q2 2019.
167 funds tracked by Wall St. Rank held Evolent Health as of Q4 2019.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2019, filed 14 Feb 2020.